| IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas C Houillier, X Wang, G Kaloshi, K Mokhtari, R Guillevin, J Laffaire, S Paris, ... Neurology 75 (17), 1560-1566, 2010 | 597 | 2010 |
| 18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi–cancer site patient … M Hatt, M Majdoub, M Vallières, F Tixier, CC Le Rest, D Groheux, ... Journal of nuclear medicine 56 (1), 38-44, 2015 | 483 | 2015 |
| Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases L Capelle, D Fontaine, E Mandonnet, L Taillandier, JL Golmard, ... Journal of neurosurgery 118 (6), 1157-1168, 2013 | 449 | 2013 |
| Epileptic seizures in diffuse low-grade gliomas in adults J Pallud, E Audureau, M Blonski, N Sanai, L Bauchet, D Fontaine, ... Brain 137 (2), 449-462, 2014 | 376 | 2014 |
| Simulation of anisotropic growth of low‐grade gliomas using diffusion tensor imaging S Jbabdi, E Mandonnet, H Duffau, L Capelle, KR Swanson, ... Magnetic Resonance in Medicine: An Official Journal of the International …, 2005 | 356 | 2005 |
| Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas J Pallud, E Mandonnet, H Duffau, M Kujas, R Guillevin, D Galanaud, ... Annals of Neurology: Official Journal of the American Neurological …, 2006 | 250 | 2006 |
| Dynamic history of low‐grade gliomas before and after temozolomide treatment D Ricard, G Kaloshi, A Amiel‐Benouaich, J Lejeune, Y Marie, ... Annals of Neurology: Official Journal of the American Neurological …, 2007 | 232 | 2007 |
| Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease A Vallée, Y Lecarpentier, R Guillevin, JN Vallée Acta biochimica et biophysica Sinica 49 (10), 853-866, 2017 | 220 | 2017 |
| Natural history of incidental World Health Organization grade II gliomas J Pallud, D Fontaine, H Duffau, E Mandonnet, N Sanai, L Taillandier, ... Annals of neurology 68 (5), 727-733, 2010 | 202 | 2010 |
| Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis A Vallée, Y Lecarpentier, R Guillevin, JN Vallée Oncotarget 8 (52), 90579, 2017 | 198 | 2017 |
| Prognostic significance of imaging contrast enhancement for WHO grade II gliomas J Pallud, L Capelle, L Taillandier, D Fontaine, E Mandonnet, R Guillevin, ... Neuro-oncology 11 (2), 176-182, 2009 | 195 | 2009 |
| Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas J Pallud, M Blonski, E Mandonnet, E Audureau, D Fontaine, N Sanai, ... Neuro-oncology 15 (5), 595-606, 2013 | 172 | 2013 |
| Vasculogenesis and angiogenesis initiation under normoxic conditions through Wnt/β-catenin pathway in gliomas A Vallée, R Guillevin, JN Vallée Reviews in the Neurosciences 29 (1), 71-91, 2017 | 140 | 2017 |
| Development of a nomogram combining clinical staging with 18F-FDG PET/CT image features in non-small-cell lung cancer stage I–III MC Desseroit, D Visvikis, F Tixier, M Majdoub, R Perdrisot, R Guillevin, ... European journal of nuclear medicine and molecular imaging 43, 1477-1485, 2016 | 126 | 2016 |
| Spine metastasis imaging: review of the literature R Guillevin, JN Vallee, F Lafitte, C Menuel, NM Duverneuil, J Chiras Journal of neuroradiology 34 (5), 311-321, 2007 | 114 | 2007 |
| Percutaneous vertebroplasty for metastatic involvement of the axis F Mont’Alverne, JN Vallée, E Cormier, R Guillevin, H Barragan, B Jean, ... American journal of neuroradiology 26 (7), 1641-1645, 2005 | 103 | 2005 |
| Efficacy of chest CT for COVID-19 pneumonia diagnosis in France G Herpe, M Lederlin, M Naudin, M Ohana, K Chaumoitre, J Gregory, ... Radiology 298 (2), E81-E87, 2021 | 100 | 2021 |
| Proton magnetic resonance spectroscopy predicts proliferative activity in diffuse low-grade gliomas R Guillevin, C Menuel, H Duffau, M Kujas, L Capelle, A Aubert, S Taillibert, ... Journal of neuro-oncology 87, 181-187, 2008 | 93 | 2008 |
| Response assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: comparative analysis of the Macdonald, RECIST, RANO, and RECIST+ F criteria JG Pérez-Larraya, M Lahutte, G Petrirena, G Reyes-Botero, ... Neuro-oncology 14 (5), 667-673, 2012 | 91 | 2012 |
| MRI features of neurodegenerative Langerhans cell histiocytosis N Martin-Duverneuil, A Idbaih, K Hoang-Xuan, J Donadieu, T Genereau, ... European radiology 16, 2074-2082, 2006 | 87 | 2006 |
